| Pulsed electric field (PEF): Avant-garde extraction escalation technology in food industry N Naliyadhara, A Kumar, S Girisa, UD Daimary, M Hegde, ... Trends in Food Science and Technology, 2022 | 105 | 2022 |
| Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials AB Kunnumakkara, M Hegde, D Parama, S Girisa, A Kumar, UD Daimary, ... ACS Pharmacology & Translational Science 6 (4), 447-518, 2023 | 87 | 2023 |
| MicroRNAs as Modulators of Oral Tumorigenesis—A Focused Review K Rishabh, S Khadilkar, A Kumar, I Kalra, AP Kumar, AB Kunnumakkara International Journal of Molecular Sciences 22 (5), 2561, 2021 | 62 | 2021 |
| EMT in breast cancer metastasis: an interplay of microRNAs, signaling pathways and circulating tumor cells A Kumar, A Golani, LD Kumar Frontiers in Bioscience-Landmark 25 (5), 979-1010, 2020 | 59 | 2020 |
| Long noncoding RNAs in triple‐negative breast cancer: A new frontier in the regulation of tumorigenesis KK Thakur, A Kumar, K Banik, E Verma, E Khatoon, C Harsha, G Sethi, ... Journal of Cellular Physiology, 2021 | 50 | 2021 |
| Current clinical developments in curcumin-based therapeutics for cancer and chronic diseases A Kumar, C Harsha, P Dey, S Girisa, UD Daimary, X Mao, ... Phytotherapy Research, 2021 | 43 | 2021 |
| Interplay of dietary antioxidants and gut microbiome in human health: What has been learnt thus far? N Naliyadhara, A Kumar, SK Gangwar, TN Devanarayanan, M Hegde, ... Journal of Functional Foods 100, 105365, 2023 | 41 | 2023 |
| Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases UD Daimary, D Parama, V Rana, K Banik, A Kumar, C Harsha, ... Current Research in Pharmacology and Drug Discovery 2, 100008, 2021 | 39 | 2021 |
| Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review E Verma, A Kumar, UD Daimary, D Parama, S Girisa, G Sethi, ... Journal of Functional Foods 86 (13), 2021 | 37 | 2021 |
| Vimentin activation in early apoptotic cancer cells errands survival pathways during DNA damage inducer CPT treatment in colon carcinoma model S Chakraborty, A Kumar, MM Faheem, A Katoch, A Kumar, VL Jamwal, ... Cell death & disease 10 (6), 1-16, 2019 | 37 | 2019 |
| From Simple Mouth Cavities to Complex Oral Mucosal Disorders—Curcuminoids as a Promising Therapeutic Approach S Girisa, A Kumar, V Rana, D Parama, UD Daimary, S Warnakulasuriya, ... ACS pharmacology & translational science 4 (2), 647-665, 2021 | 35 | 2021 |
| An overview of the pharmacological activities of scopoletin against different chronic diseases D Parama, S Girisa, E Khatoon, A Kumar, MS Alqahtani, M Abbas, G Sethi, ... Pharmacological Research 179, 106202, 2022 | 34 | 2022 |
| RNA interference and Nanotechnology: A promising alliance for next generation cancer therapeutics G Swaminathan, A Shigna, A Kumar, VV Byroju, VR Durgempudi, ... Frontiers in Nanotechnology 3, 42, 2021 | 34 | 2021 |
| Natural compounds targeting nuclear receptors for effective cancer therapy M Hegde, S Girisa, N Naliyadhara, A Kumar, MS Alqahtani, M Abbas, ... Cancer and Metastasis Reviews 42 (3), 765-822, 2023 | 26 | 2023 |
| The promising potential of piperlongumine as an emerging therapeutics for cancer D Parama, V Rana, S Girisa, E Verma, UD Daimary, KK Thakur, A Kumar, ... Exploration of Targeted Anti-tumor Therapy, 2021 | 26 | 2021 |
| Natural podophyllotoxin analog 4DPG attenuates EMT and colorectal cancer progression via activation of checkpoint kinase 2 A Katoch, D Nayak, MM Faheem, A Kumar, PK Sahu, AP Gupta, ... Cell Death Discovery 7, 25, 2021 | 25 | 2021 |
| Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics A Kumar, S Girisa, MS Alqahtani, M Abbas, M Hegde, G Sethi, ... Cells 12 (5), 2023 | 24 | 2023 |
| Combinatorial therapy using RNAi and curcumin nano-architectures regresses tumors in breast and colon cancer models A Kumar, A Singam, G Swaminathan, N Killi, NK Tangudu, J Jose, ... Nanoscale, 2021 | 24 | 2021 |
| Targeting PD-1/PD-L1 axis as new horizon for ovarian cancer therapy E Khatoon, D Parama, A Kumar, MS Alqahtani, M Abbas, S Girisa, G Sethi, ... Life Sciences 306, 120827, 2022 | 23 | 2022 |
| Multitargeting effects of calebin A on malignancy of CRC cells in the multicellular tumor microenvironment C Buhrmann, AB Kunnumakkara, A Kumar, M Samec, P Kubatka, ... Frontiers in Oncology 11, 2021 | 23 | 2021 |
Ajaikumar B KunnumakkaraProfessor, Department of Biosciences and Bioengineering, Indian Institute of Technology GuwahatiVerified email at iitg.ac.in
